DSGN logo

Design Therapeutics (DSGN) EBITDA

Annual EBITDA

-$61.79 M
+$15.87 M+20.43%

December 1, 2024


Summary


Performance

DSGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNprofitabilitymetrics:

Quarterly EBITDA

-$16.55 M
-$452.00 K-2.81%

December 1, 2024


Summary


Performance

DSGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNprofitabilitymetrics:

TTM EBITDA

-$61.79 M
-$1.56 M-2.59%

December 1, 2024


Summary


Performance

DSGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

DSGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.4%-2.8%-2.6%
3 y3 years-73.1%-2.8%-2.6%
5 y5 years-3138.3%-2.8%-2.6%

DSGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-73.1%+20.4%-49.8%+26.4%-73.1%+25.0%
5 y5-year-3138.3%+20.4%-2555.7%+26.4%-9817.7%+25.0%
alltimeall time-3138.3%+20.4%-2555.7%+26.4%-9817.7%+25.0%

Design Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$61.79 M(-20.4%)
-$16.55 M(+2.8%)
-$61.79 M(+2.6%)
Sep 2024
-
-$16.09 M(+8.1%)
-$60.23 M(-4.1%)
Jun 2024
-
-$14.89 M(+4.5%)
-$62.82 M(-10.8%)
Mar 2024
-
-$14.26 M(-4.8%)
-$70.39 M(-9.4%)
Dec 2023
-$77.65 M(+15.6%)
-$14.98 M(-19.8%)
-$77.65 M(-5.2%)
Sep 2023
-
-$18.68 M(-16.8%)
-$81.94 M(-0.5%)
Jun 2023
-
-$22.46 M(+4.4%)
-$82.34 M(+9.2%)
Mar 2023
-
-$21.52 M(+11.7%)
-$75.42 M(+12.3%)
Dec 2022
-$67.19 M
-$19.27 M(+1.0%)
-$67.19 M(+13.9%)
Sep 2022
-
-$19.08 M(+22.8%)
-$58.96 M(+15.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$15.55 M(+17.0%)
-$51.19 M(+18.2%)
Mar 2022
-
-$13.29 M(+20.3%)
-$43.31 M(+21.3%)
Dec 2021
-$35.70 M(+328.9%)
-$11.04 M(-2.3%)
-$35.70 M(+25.2%)
Sep 2021
-
-$11.31 M(+47.3%)
-$28.51 M(+45.6%)
Jun 2021
-
-$7.67 M(+35.2%)
-$19.59 M(+46.4%)
Mar 2021
-
-$5.68 M(+47.2%)
-$13.38 M(+60.7%)
Dec 2020
-$8.32 M(+336.3%)
-$3.86 M(+61.9%)
-$8.32 M(+86.3%)
Sep 2020
-
-$2.38 M(+62.8%)
-$4.47 M(+114.2%)
Jun 2020
-
-$1.46 M(+134.8%)
-$2.09 M(+234.8%)
Mar 2020
-
-$623.00 K
-$623.00 K
Dec 2019
-$1.91 M
-
-

FAQ

  • What is Design Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Design Therapeutics?
  • What is Design Therapeutics annual EBITDA year-on-year change?
  • What is Design Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Design Therapeutics?
  • What is Design Therapeutics quarterly EBITDA year-on-year change?
  • What is Design Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Design Therapeutics?
  • What is Design Therapeutics TTM EBITDA year-on-year change?

What is Design Therapeutics annual EBITDA?

The current annual EBITDA of DSGN is -$61.79 M

What is the all time high annual EBITDA for Design Therapeutics?

Design Therapeutics all-time high annual EBITDA is -$1.91 M

What is Design Therapeutics annual EBITDA year-on-year change?

Over the past year, DSGN annual EBITDA has changed by +$15.87 M (+20.43%)

What is Design Therapeutics quarterly EBITDA?

The current quarterly EBITDA of DSGN is -$16.55 M

What is the all time high quarterly EBITDA for Design Therapeutics?

Design Therapeutics all-time high quarterly EBITDA is -$623.00 K

What is Design Therapeutics quarterly EBITDA year-on-year change?

Over the past year, DSGN quarterly EBITDA has changed by -$452.00 K (-2.81%)

What is Design Therapeutics TTM EBITDA?

The current TTM EBITDA of DSGN is -$61.79 M

What is the all time high TTM EBITDA for Design Therapeutics?

Design Therapeutics all-time high TTM EBITDA is -$623.00 K

What is Design Therapeutics TTM EBITDA year-on-year change?

Over the past year, DSGN TTM EBITDA has changed by -$1.56 M (-2.59%)